| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5517 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517 |
| filingDate |
2014-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2016-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2016528266-A |
| titleOfInvention |
V1a antagonists for treating phase shift sleep disorders |
| abstract |
The present invention relates to novel medical uses of certain compounds and pharmaceutical compositions containing them. The present invention relates to compounds that are selective V1a antagonists for use in the treatment of phase shift sleep disorders, particularly jet lag. In another aspect, the present invention relates to a pharmaceutical composition comprising a compound according to the present invention and a pharmaceutically acceptable carrier for use in the treatment of a phase shift sleep disorder. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7308193-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021505531-A |
| priorityDate |
2013-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |